Explore the science, research advances, and policy shifts reshaping how we approach HIV-1 and breastfeeding - a journey from blanket prohibitions to personalized risk assessment.
Clinical trial shows switching from complex HIV regimens to single-tablet B/F/TAF maintains viral suppression with improved safety profile
How scientists are uncovering the keys to successful HIV therapy for refugees and people in conflict zones.
Exploring the scientific showdown between two-drug and three-drug HIV treatment regimens, examining efficacy, safety, and long-term benefits.
Exploring the hidden factors behind HIV treatment failure in resource-poor communities and the systemic challenges that undermine antiretroviral therapy success.
Exploring the profile of patients undergoing third-line antiretroviral therapy for HIV treatment, including drug resistance, treatment challenges, and scientific breakthroughs.
Exploring the clinical evidence comparing Tenofovir Alafenamide (TAF) and Tenofovir Disoproxil Fumarate (TDF) in HIV treatment through a 96-week randomized switch study.
Exploring the scientific detective work to understand why some patients struggle to suppress HIV despite treatment, and the innovative interventions helping close this gap.
Explore how HIV drug resistance testing helps scientists stay ahead of the virus's mutations and develop effective treatments.
How antiretroviral therapy has revolutionized pregnancy outcomes for HIV-positive women, reducing transmission rates to less than 1%.